Amin, Elianna M
WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. [electronic resource]
- Cancer cell Dec 2011
- 768-80 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
ISSN: 1878-3686
Standard No.: 10.1016/j.ccr.2011.10.016 doi
Subjects--Topical Terms: Animals Cell Line, Tumor Cell Nucleus--metabolism Choroidal Neovascularization--genetics Denys-Drash Syndrome--genetics Gene Expression Gene Expression Regulation, Neoplastic Genes, Reporter Humans Luciferases, Renilla--biosynthesis Mice Mice, Inbred C57BL Mice, Nude Neoplasm Transplantation Neoplasms--blood supply Neovascularization, Pathologic--genetics Nuclear Proteins--metabolism Podocytes--metabolism Promoter Regions, Genetic Protein Binding Protein Isoforms--genetics Protein Kinase Inhibitors--pharmacology Protein Serine-Threonine Kinases--antagonists & inhibitors Protein Transport RNA Interference RNA Splicing--genetics RNA-Binding Proteins--metabolism Serine-Arginine Splicing Factors Vascular Endothelial Growth Factor B--genetics Vascular Endothelial Growth Factor Receptor-2--metabolism WT1 Proteins--genetics